文献速递肝病

南美洲非酒精性脂肪性肝病组织病理学特征的流行病学与危险因素

Epidemiology and risk factors for histopathologic characteristics of non-alcoholic fatty liver disease in South America.
PubMed 文献 · Aliment Pharmacol Ther · 2023-06-22

描述性研究纳入南美洲5国8个医学中心的2722例非酒精性脂肪性肝病患者,分析临床特征与组织病理学特征的关联。代谢综合征、2型糖尿病和高血压与显著纤维化、重度脂肪变及肝脏炎症独立相关。2型糖尿病患病率低于已报道的全球患病率。

要点

  • 代谢综合征、2型糖尿病和高血压与显著纤维化独立相关。
  • 代谢综合征、2型糖尿病和高血压与重度脂肪变及肝脏炎症独立相关。
  • 该队列2型糖尿病患病率低于已报道的全球患病率。

核心结论

  • 在南美洲迄今最大的非酒精性脂肪性肝病队列研究中,代谢综合征、高血压和2型糖尿病与显著纤维化、重度脂肪变和炎症独立相关。
  • 2型糖尿病患病率低于已报道的全球患病率。

研究设计与样本

  • 描述性研究,纳入南美洲5个国家8个医学中心的2722例非酒精性脂肪性肝病患者。
  • 收集临床、生化和组织病理学数据,纤维化通过弹性成像或纤维化评分评估,有活检时以活检确认。
  • 采用logistic回归模型分析组织病理学特征与临床特征的关联,模型对国家、年龄和性别进行调整。

主要发现

  • 中位年龄53岁(IQR:41-62),女性占63%。
  • 巴西受试者体重指数最高,为42 kg/m2。
  • 67%有血脂异常,46%有肥胖,30%有高血压,17%有2型糖尿病,34%有代谢综合征。
  • 948例(35%)有活检报告,其中58%显示纤维化,91%显示脂肪变,65%显示炎症;25%显示显著纤维化,27%显示重度脂肪变。
  • 代谢综合征、2型糖尿病和高血压分别与显著纤维化(OR=1.94,p<0.001;OR=2.93,p<0.001;OR=1.60,p=0.003)、重度脂肪变(OR=2.05,p<0.001;OR=1.91,p=0.001;OR=2.17,p<0.001)和肝脏炎症(OR=1.66,p=0.007;OR=2.00,p=0.002;OR=1.62,p=0.001)显著相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The burden of non-alcoholic fatty liver disease (NAFLD) in South America is among the highest in the world. However, the epidemiology and risk factors for NAFLD are insufficiently described in the region. AIM: To explore the associations between clinical characteristics and histopathological features of NAFLD METHODS: This was a descriptive study of 2722 patients with NAFLD from 8 medical centres across 5 South American countries. We collected clinical, biochemical and histopathological data using a templated chart. Fibrosis was assessed by elastography or fibrosis scores and confirmed with biopsy when available. We examined associations between histopathological features and clinical characteristics with logistic regression models. Models were adjusted for country, age and sex. RESULTS: The median age was 53 years (IQR: 41-62), and 63% were women. Subjects from Brazil had the highest body mass index at 42 kg/m2 . Sixty-seven percent had dyslipidemia, 46% had obesity, 30% had hypertension, 17% had type 2 diabetes mellitus (T2DM) and 34% had metabolic syndrome. Biopsy reports were available for 948 (35%), of which 58% showed fibrosis, 91% steatosis and 65% inflammation; 25% showed significant fibrosis and 27% severe steatosis. Metabolic syndrome, T2DM and hypertension were significantly associated with significant fibrosis (OR = 1.94, p < 0.001; OR = 2.93, p < 0.001 and OR = 1.60, p = 0.003, respectively), severe steatosis (OR = 2.05, p < 0.001; OR = 1.91, p = 0.001 and OR = 2.17, p < 0.001, respectively) and liver inflammation (OR = 1.66, p = 0.007; OR = 2.00, p = 0.002; OR = 1.62, p = 0.001, respectively). CONCLUSIONS: In the largest NAFLD cohort study to date from South America, metabolic syndrome, hypertension and T2DM were independently associated with significant fibrosis, severe steatosis, and inflammation. The prevalence of T2DM was lower than the reported global prevalence.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Akambase JA, Prieto JE, Mattos AZ, et al. Epidemiology and risk factors for histopathologic characteristics of non-alcoholic fatty liver disease in South America. Aliment Pharmacol Ther. 2023. PMID: 37349900. doi:10.1111/apt.17615

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。